AI Agents & Applications · advanced · concept 161 of 176
AI-Driven Drug Discovery
Using AI to identify, design, and optimize drug candidates, dramatically accelerating the traditional 10-15 year drug development cycle. AlphaFold made protein structure prediction reliable enough to use as a tool. Insilico Medicine's rentosertib is the first candidate whose biological target and molecule were both found with generative AI, and it cleared a Phase IIa readout in 2025. It is still investigational, not approved, which is the honest state of the field.
Key terms
Protein foldingAlphaFoldMolecular generationDrug target
Learn these first
Videos
Guides and articles
AlphaFold — Google DeepMind ↗
Google DeepMind
Courses, papers, and more